CCM
INSP icon

Catalio Capital Management’s Inspire Medical Systems INSP Stock Holding History

Catalio Capital Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-85,877
Closed -$13.7M – 43
2025
Q1 		$13.7M Buy
+85,877
New +$15.5M 3.33% 13

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Catalio Capital Management's INSP Position: Q2 2025 in Review

Catalio Capital Management sold out of Inspire Medical Systems (INSP) in Q2 2025, closing a stake of 85,877 shares — an estimated $13.7M sold.

Catalio Capital Management first reported a position in INSP in Q1 2025 and held it in 1 quarter. The position peaked at $13.7M in Q1 2025. 356 funds tracked by Wall St. Rank hold INSP as of Q2 2025.

  • Catalio Capital Management reported no remaining Inspire Medical Systems position as of Q2 2025 after selling out during the quarter.
  • Catalio Capital Management sold 85,877 Inspire Medical Systems shares in Q2 2025, an estimated $13.7M.
  • Catalio Capital Management first reported a position in Inspire Medical Systems in Q1 2025 and held it in 1 quarter.
  • Catalio Capital Management's Inspire Medical Systems position peaked at $13.7M in Q1 2025.
  • 356 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2025.

Based on Catalio Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.